Prelude Therapeutics Incorporated

NASDAQ:PRLD

2.55 (USD) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q1
Operating Activities:
Net Income -34.74-31.431-33.075-30.608-30.431-27.718-28.641-29.958-27.374-29.465-32.842-30.687-26.865-21.3-19.25-16.76-11.408-9.511-10.039-6.734-0.005-0.005
Depreciation & Amortization 0.4520.4260.3310.2790.2810.2780.3620.3370.3180.3070.290.2660.1990.160.1330.1420.1350.1320.1280.09900
Deferred Income Tax 00-1.071-1.597-0.359000001.0080.3560000000000
Stock Based Compensation 6.0985.5475.9126.7156.7336.2565.8456.4426.0286.8295.7757.0334.2373.8863.1221.4720.6270.3620.3260.29700
Change In Working Capital 6.068-5.2063.717-0.926-4.334-8.936-0.7511.3151.093-0.725-0.3330.9022.2270.8291.1372.6391.744-0.9041.1060.709-0-0
Accounts Receivables 0000000000000000000000
Change In Inventory 0000000000000000000000
Change In Accounts Payables 1.0770.631-0.465-0.472-1.7070.374-3.243.731-0.840.002-3.9314.5071.7261.601-0.7740.7971.206-0.0720.6220.17700
Other Working Capital 4.991-5.8374.182-0.454-2.627-9.312.489-2.4161.933-0.7273.598-3.6050.501-0.7721.9111.8420.538-0.8320.4840.532-0-0
Other Non Cash Items 4.994.6410.6080.4540.442-0.0140.2581.4251.4671.1590.40.3560.290.2820.0110.0010.001-00.010-0-0
Operating Cash Flow -23.057-31.791-23.578-25.683-27.668-30.134-22.927-20.439-18.468-21.895-25.702-21.774-19.912-16.143-14.847-12.507-8.902-9.921-8.469-5.629-0.006-0.006
Investing Activities:
Investments In Property Plant And Equipment -0.359-0.289-1.129-0.591-0.983-0.81-0.393-0.916-0.758-0.952-0.297-0.659-0.381-0.986-0.329-0.17-0.042-0.08-0.199-0.445-0-0
Acquisitions Net 00-0.009-0.0160.074-0.019-0.002-0.023-0.0180000000000000
Purchases Of Investments -7.882-5.49-59.385-34.114-120.943-7.191-33.251-58.832-27.140-1.507-259.9730000000000
Sales Maturities Of Investments 34.363768.2549.7546.52634.99981.35545.07942.5000000000000
Other Investing Activites 00.0320.0090.016-0.0740.0190.0020.0230.0180.043-0.002-259.9730000000000
Investing Cash Flow 26.11931.2217.73615.045-75.42617.9991.35521.60717.18141.548-1.804-260.632-0.381-0.986-0.329-0.17-0.042-0.08-0.199-0.445-0-0
Financing Activities:
Debt Repayment 00000000000000-0.191-0.067-0.096-0.095-0.093-0.03100
Common Stock Issued 0.1730.00224.9360.104111.3390.0280.3890.1480.3590.1531.9540.7110.422161.424-1.299167.929000000
Common Stock Repurchased 0-0-0-00000000000-0.0010000000
Dividends Paid 0000000000000000000000
Other Financing Activities -0.114-0.0160.301-0.0160.111-0.297-0.23400.3590.1531.9540.7110.4220.3860.183217.820.03129.9420-00.0150.015
Financing Cash Flow 0.059-0.01425.2370.088111.339-0.2690.1550.1480.3590.1531.9540.7110.422161.81-1.307217.753-0.06529.847-0.093-0.0310.0150.015
Other Information:
Effect Of Forex Changes On Cash 000000000025.70200000000000
Net Change In Cash 3.121-0.5849.395-10.558.245-12.404-21.4171.316-0.92819.806-25.552-281.695-19.871144.681-16.483205.076-9.00919.846-8.761-6.1050.0090.009
Cash At End Of Period 27.82824.70729.33519.9430.4922.24534.64956.06654.7555.67835.87261.424343.119362.99218.309234.79229.71638.72518.87927.640.0340.009